Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries

Aim To assess the differences in the cost-effectiveness of oral triptan therapy for migraines among European countries. Methods A cost-effectiveness analysis of triptan therapy for migraine was conducted from a health-care payer perspective in four European countries (France, Italy, Spain and the UK...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The European journal of health economics 2014-05, Vol.15 (4), p.433-437
Hauptverfasser:	Hens, Manuel, Villaverde-Hueso, Ana, Alonso, Veronica, Abaitua, Ignacio, de la Paz, Manuel Posada
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Analgesics Average cost Brand name drugs Brand names Cost analysis Cost benefit analysis Decision making Decision Trees Dosage Drug costs Drug design Drug dosages Drug therapy Economic costs Economic Policy Europe Generic drugs Headache Health Care Management Health Economics Humans Medical practice Medicine Medicine & Public Health Migraine Migraine Disorders - drug therapy Original Paper Pain Pharmacoeconomics and Health Outcomes Pharmacy Public Finance Public Health Recommendations Studies Tryptamines - administration & dosage Tryptamines - economics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!